<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03364972</url>
  </required_header>
  <id_info>
    <org_study_id>232017</org_study_id>
    <nct_id>NCT03364972</nct_id>
  </id_info>
  <brief_title>A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00</brief_title>
  <official_title>A Randomised, Controlled Study to Compare Visual Performance, Refractive Outcome, Forward Light Scatter, Patient Satisfaction and Objective Measurement of Glistenings Following Insertion of Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00 Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>City, University of London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a bilateral randomised controlled study to compare visual performance, refractive
      outcome, forward light scatter, patient satisfaction and objective measurement of glistenings
      following insertion of two monofocal, aspheric, hydrophobic acrylic intraocular lenses
      (IOLs). A new product is compared with an established one.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>13 months</time_frame>
    <description>As measured by conventional LogMAR visual acuity charts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of intraocular lens glistenings</measure>
    <time_frame>13 months</time_frame>
    <description>Incidence of presence of intraocular lens glistenings in each study arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of intraocular lens glistenings</measure>
    <time_frame>13 months</time_frame>
    <description>Number of vacuoles per square millimetre</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refraction (i.e. glasses prescription)</measure>
    <time_frame>13 months</time_frame>
    <description>In conventional sphere/cylinder dioptre scales: total range -40 to +40, in 0.25 steps. Higher values represent worse outcome. Values closer to 0 (zero) represent better outcome</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Forward light scatter</measure>
    <time_frame>13 months</time_frame>
    <description>Intraocular (forward) light scatter is measured with a specifically devised computerised vision test. It is represented by straylight parameter, Log(s), on a logarithmic scale from 0 to 1.5. The lower the value (i.e. closer to 0), the better the outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>13 months</time_frame>
    <description>Visual acuity (LogMAR scale: total range -0.2 to 1.0 in 0.02 steps) measured at different contrasts with a computerized contrast sensitivity chart. Negative values, or values closer to 0, represent better outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>13 months</time_frame>
    <description>Validated patient satisfaction questionnaire. We use specially designed and validated conversion tables to convert raw scores from questionnaires to Rasch calibrated measures.</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-reported health</measure>
    <time_frame>13 months</time_frame>
    <description>Validated self-reported health questionnaire. We use a vertical Visual Analogue Scale (VAS) to record patients' self-reported health on a scale from 0-100 (values closer or equal to 100 represent better outcome).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Cataract Extraction</condition>
  <condition>Phacoemulsification</condition>
  <condition>Glistenings</condition>
  <condition>Intraocular Lens Implant</condition>
  <condition>Hydrophobic Acrylic</condition>
  <condition>Cataract Surgery</condition>
  <condition>Light Scatter</condition>
  <condition>Patient Satisfaction</condition>
  <condition>Patient Related Outcome Measures</condition>
  <arm_group>
    <arm_group_label>Experimental intraocular lens implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>'Alcon Clareon' : New monofocal, hydrophobic acrylic intraocular lens implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard intraocular lens implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Abbott Tecnis PCB00- Standard monofocal,hydrophobic acrylic intraocular lens implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cataract surgery</intervention_name>
    <description>Conventional small-incision phacoemulsification cataract surgery with insertion of intraocular lens implant</description>
    <arm_group_label>Experimental intraocular lens implant</arm_group_label>
    <arm_group_label>Standard intraocular lens implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bilateral cataracts

          -  good visual potential

          -  ability to understand informed consent and objectives of the trial

          -  not-pregnant

          -  not breast feeding

          -  no previous eye surgery

          -  corneal astigmatism less than 1 diopter in both eyes

        Exclusion Criteria:

          -  age-related macula degeneration

          -  glaucoma

          -  previous retinal vascular disorders

          -  previous retinal detachment or tear

          -  any neuro-ophthalmological condition

          -  any inherited retinal disorder or pathology

          -  previous strabismus surgery or record of amblyopia

          -  previous transient ischaemic attacks, cerebrovascular events or other vaso-occlusive
             disease

          -  already enrolled in another study

          -  Exclusion criteria relate to clinical contraindications for Femtosecond Laser Assisted
             Cataract Surgery, such as:

               -  Significant corneal opacities

               -  Small pupils following pharmacological dilatation

               -  Patients unable to lie sufficiently flat so as to be positioned underneath the
                  laser machine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St Thomas' Hospital NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Stanojcic, MBBS BSc MCOptom FRCOphth</last_name>
      <phone>02071884336</phone>
      <email>nikola.stanojcic@gstt.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2017</study_first_submitted>
  <study_first_submitted_qc>December 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2017</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cataract</keyword>
  <keyword>cataract extraction</keyword>
  <keyword>interocular lens implant</keyword>
  <keyword>glistenings</keyword>
  <keyword>phacoemulsification</keyword>
  <keyword>hydrophobic acrylic</keyword>
  <keyword>light scatter</keyword>
  <keyword>patient related outcome measures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

